• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前沿:TIGIT 具有 T 细胞内在抑制功能。

Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.

机构信息

Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

出版信息

J Immunol. 2011 Feb 1;186(3):1338-42. doi: 10.4049/jimmunol.1003081. Epub 2011 Jan 3.

DOI:10.4049/jimmunol.1003081
PMID:21199897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3128994/
Abstract

Costimulatory molecules regulate the functional outcome of T cell activation, and disturbance of the balance between activating and inhibitory signals results in increased susceptibility to infection or the induction of autoimmunity. Similar to the well-characterized CD28/CTLA-4 costimulatory pathway, a newly emerging pathway consisting of CD226 and T cell Ig and ITIM domain (TIGIT) has been associated with susceptibility to multiple autoimmune diseases. In this study, we examined the role of the putative coinhibitory molecule TIGIT and show that loss of TIGIT in mice results in hyperproliferative T cell responses and increased susceptibility to autoimmunity. TIGIT is thought to indirectly inhibit T cell responses by the induction of tolerogenic dendritic cells. By generating an agonistic anti-TIGIT Ab, we demonstrate that TIGIT can inhibit T cell responses directly independent of APCs. Microarray analysis of T cells stimulated with agonistic anti-TIGIT Ab revealed that TIGIT can act directly on T cells by attenuating TCR-driven activation signals.

摘要

共刺激分子调节 T 细胞激活的功能结果,激活和抑制信号之间平衡的破坏导致易感性增加感染或自身免疫的诱导。类似于特征明确的 CD28/CTLA-4 共刺激途径,由 CD226 和 T 细胞免疫球蛋白和 ITIM 结构域(TIGIT)组成的新出现的途径与多种自身免疫性疾病的易感性相关。在这项研究中,我们研究了假定的共抑制分子 TIGIT 的作用,并表明小鼠中 TIGIT 的缺失导致 T 细胞过度增殖反应和自身免疫易感性增加。TIGIT 被认为通过诱导耐受树突状细胞间接抑制 T 细胞反应。通过产生激动性抗 TIGIT Ab,我们证明 TIGIT 可以直接抑制 T 细胞反应而不依赖于 APC。用激动性抗 TIGIT Ab 刺激的 T 细胞的微阵列分析表明,TIGIT 可以通过减弱 TCR 驱动的激活信号直接作用于 T 细胞。

相似文献

1
Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.前沿:TIGIT 具有 T 细胞内在抑制功能。
J Immunol. 2011 Feb 1;186(3):1338-42. doi: 10.4049/jimmunol.1003081. Epub 2011 Jan 3.
2
The TIGIT/CD226 axis regulates human T cell function.TIGIT/CD226 轴调节人类 T 细胞功能。
J Immunol. 2012 Apr 15;188(8):3869-75. doi: 10.4049/jimmunol.1103627. Epub 2012 Mar 16.
3
Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation.B7-1 二聚体和单体的动态平衡对 TCR/CD28 刺激引起的免疫突触形成和 T 细胞激活有不同的影响。
J Immunol. 2010 Feb 15;184(4):1821-8. doi: 10.4049/jimmunol.0902869. Epub 2010 Jan 11.
4
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function.基于 TIGIT 的嵌合共刺激开关受体改善 T 细胞抗肿瘤功能。
J Immunother Cancer. 2019 Sep 9;7(1):243. doi: 10.1186/s40425-019-0721-y.
5
CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.CD226 通过 CTLA-4 和 TIGIT 在 EAE 中减弱 Treg 的抑制能力。
Immunol Res. 2019 Dec;67(6):486-496. doi: 10.1007/s12026-019-09112-9.
6
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.表面蛋白TIGIT通过促进成熟免疫调节性树突状细胞的生成来抑制T细胞活化。
Nat Immunol. 2009 Jan;10(1):48-57. doi: 10.1038/ni.1674. Epub 2008 Nov 16.
7
Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development.激动性抗 TIGIT 治疗可抑制 LDLr 缺陷小鼠的 T 细胞反应,而不影响动脉粥样硬化病变的发展。
PLoS One. 2013 Dec 20;8(12):e83134. doi: 10.1371/journal.pone.0083134. eCollection 2013.
8
A retro-inverso peptide mimic of CD28 encompassing the MYPPPY motif adopts a polyproline type II helix and inhibits encephalitogenic T cells in vitro.一种包含MYPPPY基序的CD28反向模拟肽形成了II型多聚脯氨酸螺旋,并在体外抑制致脑炎性T细胞。
J Immunol. 2001 Jul 1;167(1):578-85. doi: 10.4049/jimmunol.167.1.578.
9
Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development.T细胞发育过程中DRAK2异位表达导致胸腺选择改变及自身免疫增加。
J Immunol. 2009 Jul 1;183(1):285-97. doi: 10.4049/jimmunol.0803530.
10
Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4.饱和脂肪酸和多不饱和脂肪酸相互调节通过Toll样受体4(TLR4)介导的树突状细胞功能。
J Immunol. 2005 May 1;174(9):5390-7. doi: 10.4049/jimmunol.174.9.5390.

引用本文的文献

1
TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies.癌症中的TIGIT:从作用机制到有前景的免疫治疗策略
Cell Death Dis. 2025 Sep 1;16(1):664. doi: 10.1038/s41419-025-07984-4.
2
Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphoma.淋巴结转录组图谱提示经典型霍奇金淋巴瘤对博来霉素诱导的肺毒性易感。
Sci Rep. 2025 Aug 18;15(1):30273. doi: 10.1038/s41598-025-16218-8.
3
TIGIT, as a potential immune checkpoint target for immunotherapy of breast cancer.

本文引用的文献

1
CTLA-4 blockade: therapeutic potential in cancer treatments.CTLA-4 阻断:癌症治疗中的治疗潜力。
Onco Targets Ther. 2010 Jun 24;3:15-25. doi: 10.2147/ott.s4833.
2
PD-1 signaling in primary T cells.初始T细胞中的PD-1信号传导。
Immunol Rev. 2009 May;229(1):114-25. doi: 10.1111/j.1600-065X.2009.00767.x.
3
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.表面蛋白TIGIT通过促进成熟免疫调节性树突状细胞的生成来抑制T细胞活化。
TIGIT作为乳腺癌免疫治疗的潜在免疫检查点靶点。
Med Oncol. 2025 Aug 5;42(9):407. doi: 10.1007/s12032-025-02955-3.
4
The value of acetylation reader YEATS2 in hepatocellular carcinoma management.乙酰化阅读器YEATS2在肝细胞癌治疗中的价值
Sci Rep. 2025 Jul 29;15(1):27613. doi: 10.1038/s41598-025-09945-5.
5
Anti-TIGIT therapies: a review of preclinical and clinical efficacy and mechanisms.抗TIGIT疗法:临床前及临床疗效与机制综述
Cancer Immunol Immunother. 2025 Jul 15;74(8):272. doi: 10.1007/s00262-025-04128-7.
6
Advancements in non-invasive visualization of the immune checkpoint TIGIT: a systematic review.免疫检查点TIGIT的非侵入性可视化进展:一项系统综述
Eur J Nucl Med Mol Imaging. 2025 Jul 15. doi: 10.1007/s00259-025-07439-0.
7
Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective.从分子角度看癌症治疗中使用免疫检查点抑制剂(ICI)和抗血管生成药物的基本原理。
Clin Exp Med. 2025 Jul 8;25(1):238. doi: 10.1007/s10238-025-01751-7.
8
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine.B细胞淋巴瘤免疫治疗的新视野:从免疫检查点到精准医学
Neoplasia. 2025 Jun 30;67:101206. doi: 10.1016/j.neo.2025.101206.
9
Granzyme K CD8 T cells slow tauopathy progression by targeting microglia.颗粒酶K CD8 T细胞通过靶向小胶质细胞减缓tau蛋白病进展。
Nat Immunol. 2025 Jun 24. doi: 10.1038/s41590-025-02198-4.
10
Emerging Immunotherapy Targets in Early Drug Development.早期药物研发中新兴的免疫治疗靶点
Int J Mol Sci. 2025 Jun 4;26(11):5394. doi: 10.3390/ijms26115394.
Nat Immunol. 2009 Jan;10(1):48-57. doi: 10.1038/ni.1674. Epub 2008 Nov 16.
4
CD226 Gly307Ser association with multiple autoimmune diseases.CD226基因第307位密码子甘氨酸突变为丝氨酸与多种自身免疫性疾病的关联
Genes Immun. 2009 Jan;10(1):5-10. doi: 10.1038/gene.2008.82. Epub 2008 Oct 30.
5
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.阿巴西普或英夫利昔单抗对比安慰剂治疗类风湿关节炎(对甲氨蝶呤反应不足)的疗效与安全性:ATTEST一项III期、多中心、随机、双盲、安慰剂对照研究
Ann Rheum Dis. 2008 Aug;67(8):1096-103. doi: 10.1136/ard.2007.080002. Epub 2007 Nov 29.
6
Synaptic destabilization by neuronal Nogo-A.神经元Nogo-A导致的突触不稳定
Brain Cell Biol. 2006 Jun;35(2-3):137-56. doi: 10.1007/s11068-007-9014-3. Epub 2007 Oct 4.
7
Linear models and empirical bayes methods for assessing differential expression in microarray experiments.用于评估微阵列实验中差异表达的线性模型和经验贝叶斯方法。
Stat Appl Genet Mol Biol. 2004;3:Article3. doi: 10.2202/1544-6115.1027. Epub 2004 Feb 12.
8
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.基因集富集分析:一种基于知识的方法用于解读全基因组表达谱。
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50. doi: 10.1073/pnas.0506580102. Epub 2005 Sep 30.
9
CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions.CD226特异性表达于Th1细胞表面,并调节其增殖和效应功能。
J Immunol. 2005 Aug 1;175(3):1558-65. doi: 10.4049/jimmunol.175.3.1558.
10
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).DNAX辅助分子-1(CD226)与其配体脊髓灰质炎病毒受体(CD155)和nectin-2(PRR-2/CD112)相互作用的功能特性
Int Immunol. 2004 Apr;16(4):533-8. doi: 10.1093/intimm/dxh059.